Edition:
United States

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,475.75INR
23 Jun 2017
Change (% chg)

Rs6.60 (+0.27%)
Prev Close
Rs2,469.15
Open
Rs2,459.95
Day's High
Rs2,489.95
Day's Low
Rs2,434.05
Volume
10,033
Avg. Vol
10,307
52-wk High
Rs3,545.05
52-wk Low
Rs2,201.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 26 Jun 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 1 2 2 2
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 7 7 7 7
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.15 3.07 3.07 3.07

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 1 7,292.00 7,292.00 7,292.00 --
Year Ending Mar-17 9 29,429.40 31,443.30 28,000.00 --
Year Ending Mar-18 9 32,738.10 35,308.10 31,338.00 36,603.40
Year Ending Mar-19 9 36,904.00 40,846.10 35,143.00 --
Earnings (per share)
Year Ending Mar-17 8 38.34 49.50 32.00 --
Year Ending Mar-18 8 47.99 55.42 38.30 76.26
Year Ending Mar-19 8 56.08 64.90 40.31 --

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 7,292.00 -- -- -- --
Year Ending Mar-17 29,429.40 -- -- -- --
Year Ending Mar-18 32,738.10 32,738.10 32,725.80 33,187.90 36,603.40
Year Ending Mar-19 36,904.00 36,904.00 36,995.60 37,760.80 --
Earnings (per share)
Year Ending Mar-17 38.34 -- -- -- --
Year Ending Mar-18 47.99 47.99 49.04 54.44 76.26
Year Ending Mar-19 56.08 56.08 55.11 58.39 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 -- -- -- --
Year Ending Mar-17 -- -- -- --
Year Ending Mar-18 0 0 1 1
Year Ending Mar-19 0 0 0 2
Earnings
Year Ending Mar-17 -- -- -- --
Year Ending Mar-18 0 0 1 2
Year Ending Mar-19 0 0 1 1

More From Around the Web